200 related articles for article (PubMed ID: 12538657)
21. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes.
Honey K; Duff M; Beers C; Brissette WH; Elliott EA; Peters C; Maric M; Cresswell P; Rudensky A
J Biol Chem; 2001 Jun; 276(25):22573-8. PubMed ID: 11306582
[TBL] [Abstract][Full Text] [Related]
23. Lysosomal cysteine proteases and antigen presentation.
Rudensky A; Beers C
Ernst Schering Res Found Workshop; 2006; (56):81-95. PubMed ID: 16329647
[TBL] [Abstract][Full Text] [Related]
24. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.
Nakagawa TY; Brissette WH; Lira PD; Griffiths RJ; Petrushova N; Stock J; McNeish JD; Eastman SE; Howard ED; Clarke SR; Rosloniec EF; Elliott EA; Rudensky AY
Immunity; 1999 Feb; 10(2):207-17. PubMed ID: 10072073
[TBL] [Abstract][Full Text] [Related]
25. Proteases, processing, and thymic selection.
Cresswell P
Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
[No Abstract] [Full Text] [Related]
26. Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
Zavasnik-Bergant V; Sekirnik A; Golouh R; Turk V; Kos J
Biol Chem; 2001 May; 382(5):799-804. PubMed ID: 11517933
[TBL] [Abstract][Full Text] [Related]
27. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
Nakagawa TY; Rudensky AY
Immunol Rev; 1999 Dec; 172():121-9. PubMed ID: 10631942
[TBL] [Abstract][Full Text] [Related]
28. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
Hershberg RM; Framson PE; Cho DH; Lee LY; Kovats S; Beitz J; Blum JS; Nepom GT
J Clin Invest; 1997 Jul; 100(1):204-15. PubMed ID: 9202073
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin L maturation and activity is impaired in macrophages harboring M. avium and M. tuberculosis.
Nepal RM; Mampe S; Shaffer B; Erickson AH; Bryant P
Int Immunol; 2006 Jun; 18(6):931-9. PubMed ID: 16636015
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
Mihelic M; Dobersek A; Guncar G; Turk D
J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
[TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
32. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
Rodriguez GM; Diment S
Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes.
Zavasnik-Bergant V; Schweiger A; Bevec T; Golouh R; Turk V; Kos J
Immunology; 2004 Jul; 112(3):378-85. PubMed ID: 15196205
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma.
Schwarz G; Boehncke WH; Braun M; Schröter CJ; Burster T; Flad T; Dressel D; Weber E; Schmid H; Kalbacher H
J Invest Dermatol; 2002 Jul; 119(1):44-9. PubMed ID: 12164923
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin S activity regulates antigen presentation and immunity.
Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
[TBL] [Abstract][Full Text] [Related]
36. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.
Bania J; Gatti E; Lelouard H; David A; Cappello F; Weber E; Camosseto V; Pierre P
Proc Natl Acad Sci U S A; 2003 May; 100(11):6664-9. PubMed ID: 12748383
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin L activity controls adipogenesis and glucose tolerance.
Yang M; Zhang Y; Pan J; Sun J; Liu J; Libby P; Sukhova GK; Doria A; Katunuma N; Peroni OD; Guerre-Millo M; Kahn BB; Clement K; Shi GP
Nat Cell Biol; 2007 Aug; 9(8):970-7. PubMed ID: 17643114
[TBL] [Abstract][Full Text] [Related]
38. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages.
Lewis TA; Hartmann CB; McCoy KL
J Immunol; 1998 Sep; 161(5):2151-7. PubMed ID: 9725206
[TBL] [Abstract][Full Text] [Related]
39. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
40. Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates.
Oliveira M; Torquato RJ; Alves MF; Juliano MA; Brömme D; Barros NM; Carmona AK
Peptides; 2010 Apr; 31(4):562-7. PubMed ID: 20045715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
